The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

ORLANDO, Fla. (Ivanhoe Newswire) - Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has advanced ...

INDIANAPOLIS (WISH) — Prostate cancer remains a significant health concern, being the second leading cause of death among men, particularly affecting black men. Early detection of prostate cancer is ...

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 ...

The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic Testing for Patients with Advanced Prostate ...

IT affects one in eight men, and so it seems logical to have a prostate cancer screening programme. And yet, in a pivotal ...